Page - 71 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Image of the Page - 71 -
Text of the Page - 71 -
Conniotet al. Nanocarriers for immunecell targetingand tracking
growthsuppressionandmetastasis(Chenetal.,2014b).Highlev-
elsofindoleamine2,3-dioxygenasehavealsobeenfoundintumor
microenvironment, reducing tryptophanpool levels,whichdrive
TlymphocytestobearrestedatG1phaseofthecellcycle(Ahmad
etal., 2004).
TUMORMICROENVIRONMENT:TUMOR-INFLITRATINGIMMUNECELLS
ANDRELATEDREGULATORYPATHWAYS
The progress of cancer disease results from severalmechanisms
developed by tumors to evade antitumor immune responses
(SectionCancer immune evasionmechanisms), which has been
associatedmostly to tumormicroenvironmentmolecular path-
waysandinfiltratingcellsat thisparticularregion,ratherthanthe
ignoranceanddefectsofanti-tumorTcells (Gajewskietal.,2013;
Ma et al., 2013). In fact, the presence of different cells and their
dynamic interactionwithmalignant cells have aprofound effect
on tumorprogression (Mishra et al., 2010;Bussolati et al., 2011;
Cortez-Retamozoetal., 2012;RahirandMoser,2012).
It iswidelyaccepted that thedensityofTcell infiltrateswithin
tumormicroenvironment is the most important factor to pre-
dictcancerpatients’ survival (Eerolaetal.,2000;Obleetal.,2009;
Mahmoudet al., 2011).Nevertheless,macrophages are also cur-
rently recognizedas a fundamental cell type.As aheterogeneous
population,itsdualfunctiontowardcancerisdeterminedbytheir
polarization status (Mantovani and Sica, 2010). Macrophages
are regulated by transcription factors, whichwill lead to differ-
ent phenotypes of tumor-associatedmacrophages (TAMs). M1
and M2 have been already characterized, being associated to
the pathogenesis of several diseases, namely inflammatory and
tumordiseases (Sica et al., 2006). Indeed, pro-inflammatoryM1
macrophages, afterbeingactivatedby IFN-γ, favorTh1 immune
cell activity andpotentiate theeradicationofmalignant cells.On
the other hand,M2 phenotype enables Th2 immune responses
andregulate tissuerepair,presentingpro-tumoralabilities insev-
eral tumor types (Sica andMantovani, 2012; Cornelissen et al.,
2014). Moreover, the production of several cytokines, such as
IL-1, IL-6, IL-10,VEGF, andTGF-βbyM2TAMselicits thepro-
liferation andmetastasis of tumor cells (Biswas andMantovani,
2010). As a result, it has been described that the number ofM2
macrophages and the overallM2/M1 ratio of TAMs are impor-
tant predictors of survival for distinct types of cancers, namely
melanoma (Erdag et al., 2012;Herwig et al., 2013), ovarian can-
cer(Lanetal.,2013;Colvin,2014),T-cell (Niinoetal.,2010),and
B-cell lymphomas (Nam et al., 2014), breast (Leek et al., 1996)
andpancreaticcancer(Inoetal., 2013).
It is important tomentionhowever that theM1andM2clas-
sification of TAMs is not static, being usually very complex and
seems to be dictated by several mediators resultant from cel-
lular cross-talk and environmental conditions (Cai et al., 2012;
Escribese et al., 2012; Shimeet al., 2012). Even tough, the causes
underlying thedifferentiationofTAMstoM1orM2phenotypes
are not yet fully understood. Type I interferon pathway seems
tobe fundamental for the activationof innate immune response
against tumorcells.However, theproductionof type I interferon
byDCsremainanunderexplored issue(Fuertesetal., 2011).
DCs are alsopresentwithin tumormicroenvironment,where
they can recognize and capture live and dying tumor cells (Dhodapkar et al., 2008; Ma et al., 2013). Their presence in
tumorsofdifferent stagesandgradescorrelates toprolongeddis-
ease survival and lower invasiveness, as reviewed inPalucka and
Banchereau (2012). Even though, some of this heterogeneous
hematopoietic lineage displays anti-tumor effects while others
present immunosuppressive functions at tumor site. Actually,
tumor-infiltratingDCs functionalitymay vary according to the
combinationof environmental factors andpathwayswithinvari-
able tumor site.AmongDCsubsets, it shouldbeemphasized the
roleof tumor-infiltratingplasmacytoidDCs(pDCs)andCD8α+
DCslineage,being thefirstoftenrelated toTcell tolerance,while
the latter is in fact particularly efficient in the cross-presentation
of antigens via MHCI pathways and thus in cytotoxic T-cell
immunity(Hildneretal.,2008;Fuertesetal.,2011;Watkinsetal.,
2011).
The characterization of different solid tumors, asmelanoma,
showed thepresenceof tumor-infiltrating lymphoid cell lineage,
includingCD8+Tcells. Their function ismainly compromised
by immune system-inhibitorypathways at tumormicroenviron-
ment, enablingT cell anergy (Gajewski et al., 2013). It has been
reported thepresenceofhighamountsofCD4+Foxp3+ regula-
toryTcells(Tregcells)thatareattractedbythechemokineCCL22
via CCR4 (Toulza et al., 2010; Spranger et al., 2013). However,
the functionofT-cell subsetswithin tumormicroenvironment is
highlycomplex,dependingonseveral factors, suchas the typeof
receptorsprimed.
Another hypothesis for the presence of T cells within the
tumormicroenvironmentofcertaintumorsmayberelatedtothe
formationofalymphnode-likestructurecalledtertiarylymphoid
tissues, where it is possible to findB cells, T cells and activated
DCs (Messina et al., 2012). Still, it is not clear if the formation
of those lymphoidstructures is involved intumorgrowth invivo.
On theotherhand, tumor-infiltratedTcells can expressCCL21.
CCL21 is related to tumor tolerance by stimulatingnaïveT cells
towhich thepresentationofTAAswillnotbeefficientdue to the
absenceofco-stimulatory factors (Shieldsetal., 2010).
NK,NKTandγδTcellsalsoseemtohaveanimportantrole in
theimmunomodulationoftumormicroenvironment(Pengetal.,
2007;Mishra et al., 2010;Marcu-Malina et al., 2011; Liu et al.,
2012). The antitumor effect ofNKhas been linked to solid and
hematopoietic tumors, whileγδTcells andNKTcells have been
involved in tumor inhibition.However, they showimmunoregu-
latory functions incertain circumstances that arenot completely
known(Pengetal.,2007;Mishraetal.,2010;Marcu-Malinaetal.,
2011; Liu et al., 2012).Apromising strategyhasbeen focused in
the stimulation of DCs by α-galactosylceramide to primeNKT,
promoting theproductionof IFN-γ (Shimizuetal., 2013).
Besides these cells, tumor stroma has also been associated
with tumor growth and includes different elements as colla-
gen, endothelial cells, fibroblast and severalmacrophage subsets,
whichcontributesfortumorimmuneevasion.Inaddition,higher
levelsofangiogenic factorswere foundintumorswhere thepres-
ence of tumor-infiltrating T cells is poor (Danhier et al., 2010).
Themajorimmunosuppressivemechanismsincludethesecretion
of IL-10,TGF-β, andCCL22byM2macrophages (Condeelis and
Pollard,2006).ThetraffickingofTcellswithintumormicroenvi-
ronmenthasbeenrelatedtothesecretionofdifferentchemokines
Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 71
Cancer Nanotheranostics
What Have We Learnd So Far?
- Title
- Cancer Nanotheranostics
- Subtitle
- What Have We Learnd So Far?
- Authors
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Editor
- Frontiers in Chemistry
- Date
- 2016
- Language
- English
- License
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Size
- 21.0 x 27.7 cm
- Pages
- 132
- Keywords
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Categories
- Naturwissenschaften Chemie